CSI Market
Sign In | Register

Ars Pharmaceuticals Inc (SPRY) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access SPRY Annual Balance Sheets →
Balance sheet patterns shown here provide context for understanding Ars Pharmaceuticals Inc's financial stability and long-term positioning.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/SPRY/balance-sheets
https://api.csimarket.com/api/v1/companies/SPRY/fundamentals
https://api.csimarket.com/api/v1/companies/SPRY/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent25.62
Short-term Investments, Total112.73
Cash & Short-term Investments137.00
Accounts receivable52.76
Inventories33.43
Other Current Assets0.00
Prepaid Expense And Other Assets Current8.21
Total Current Assets211.03
Equipment/Property/Plant Net1.93
Intangible Assets13.62
Other Assets, Noncurrent3.19
Inventory Current8.82
Operating Lease Right Of Use Asset-
Total Assets251.48
Liabilities
Accounts Payable and Accrued Liabilities, Current LI63.79
Accrued Liabilities, Current7.20
Other Liabilities, Current0.00
Total Current Liabilities64.90
Long-term debt121.81
Total Long-term Debt121.81
Other liabilities, Noncurrent76.73
ContractWithCustomerLiabilityNoncurrent0.98
Contract With Customer Liability Current0.76
Total Liabilities263.44
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock441.29
Retained Earnings / Accumulated Deficit-453.15
Accumulated Other Comprehensive Income-0.10
Other Equity-0.10
Common Stockholder's Equity-11.96
Total Stockholder's Equity-11.96
Liabilities & Stockholder's Equity251.48
4 historic quarters locked

Sign in to unlock the full Ars Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Ars Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-449778

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI